The 3 Years vs 1 Year DAPT After XINSORB BRS Implantation
Status:
Not yet recruiting
Trial end date:
2026-04-01
Target enrollment:
Participant gender:
Summary
The aim of the SPARTA trial is to clarify the impact of extending DAPT beyond 1 year after
XINSORB BRS implantation by investigating the balance of risk and benefit in a broad
population of treated patients.